“How Many Planets Are You Consuming?” Launch of MyGlimpact App for Consumers Reveals Their True Environmental Footprint
June 07, 2024 08:00 ET
|
Glimpact
NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- Glimpact, the leading platform for analyzing the overall systemic environmental impact of products and organizations, today launched MyGlimpact, an app...
ChildCare Education Institute Offers No-Cost Online Course on Discovering Life Science with Young Children
June 06, 2024 12:30 ET
|
ChildCare Education Institute
ATLANTA, GA, June 06, 2024 (GLOBE NEWSWIRE) -- ChildCare Education Institute® (CCEI), an online child care training provider dedicated exclusively to the early care and education workforce, offers...
General Atomics Innovations Drive Breakthroughs in Inertial Fusion and Enable Repeated Fusion Ignition Experiments at the National Ignition Facility
June 03, 2024 10:17 ET
|
General Atomics
San Diego, CA, June 03, 2024 (GLOBE NEWSWIRE) -- A new tool developed by General Atomics (GA) is enabling scientists to optimize the quality of targets used in Inertial Confinement Fusion (ICF)...
AB Science fournit un résumé de la conférence virtuelle qui s'est tenue le 30 mai 2024, faisant le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA
May 31, 2024 10:30 ET
|
AB Science
COMMUNIQUE DE PRESSE RESUME DE LA CONFERENCE VIRTUELLE DU 30 MAI 2024 FAISANT LE POINT SUR LA DEMANDE D'AUTORISATION CONDITIONNELLE DE MISE SUR LE MARCHE DU MASITINIB DANS LE TRAITEMENT...
AB Science is providing a summary of the live webcast held on May 30, 2024, giving an update on the application for conditional marketing authorization of masitinib in ALS
May 31, 2024 10:30 ET
|
AB Science
PRESS RELEASE SUMMARY OF THE WEBCAST HELD ON MAY 30, 2024, PROVIDING AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF AMYOTROPHIC...
AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA
May 29, 2024 12:02 ET
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE FAIT LE POINT SUR LA DEMANDE D'AUTORISATION CONDITIONNELLE DE MISE SUR LE MARCHÉ DU MASITINIB DANS LE TRAITEMENT DE LA SCLÉROSE LATÉRALE AMYOTROPHIQUE Paris, 29 mai...
AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
May 29, 2024 12:02 ET
|
AB Science
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Paris, 29 May, 2024, 6pm CET AB...
Amyotrophic Lateral Sclerosis Market On Track For USD 1,271.6 Mn Revenue By 2033, Growing At 6.5% CAGR | Dimension Market Research
May 28, 2024 11:21 ET
|
Dimension Market Research
New York, May 28, 2024 (GLOBE NEWSWIRE) -- Market Overview The Global Amyotrophic Lateral Sclerosis Market size was valued at USD 673.4 million in 2023 and is further anticipated to reach USD...
Steelworkers head into fourth week of strike, call on SNOLAB to bargain fair contract
May 28, 2024 09:15 ET
|
United Steelworkers union
Steelworkers head into fourth week of strike, call on SNOLAB to bargain fair contract.
Microplastics and human health: scientist sets record straight
May 28, 2024 08:38 ET
|
International Bottled Water Association
Alexandria, VA, May 28, 2024 (GLOBE NEWSWIRE) -- Common myths about the environmental impact of plastic and concerns about microplastics on human health are debunked by an independent scientist in...